当前位置:首页 - 行情中心 - 海翔药业(002099) - 财务分析 - 利润表

海翔药业

(002099)

5.59

0.01  (0.18%)

今开:5.62最高:5.72成交:16.34万手 市盈:0.00 上证指数:3135.08   -0.20%2018-05-28
昨收:5.58 最低:5.55 换手:0.00%振幅:0.00 深证指数:10465.54  0.17%15:02:03

集合

竞价

利润表

按照会计年度查询:
报告期2018-03-312017-12-312017-09-302017-06-30
一、营业总收入610,754,044.642,308,922,170.291,721,734,395.611,227,969,565.31
营业收入610,754,044.642,308,922,170.291,721,734,395.611,227,969,565.31
二、营业总成本550,796,225.351,950,977,271.921,392,541,794.56941,119,397.75
营业成本355,150,701.211,317,395,106.66966,755,997.68674,465,392.83
营业税金及附加7,561,598.827,508,270.2117,602,773.1412,517,932.55
销售费用5,332,419.1239,274,842.6423,039,535.6614,245,776.51
管理费用97,692,175.08423,374,490.35289,883,974.49186,050,199.43
财务费用84,704,153.96141,778,261.82100,664,808.3156,331,452.34
资产减值损失355,177.181,646,300.24-5,405,294.72-2,491,355.91
三、其他经营收益86,998.819,189.52-282,667.75-207,662.64
允许价值变动净收益5,010,265.7-5,010,265.7-2,433,510.95-1,922,905.5
投资净收益-5,810,881.1636,897,265.286,404,153.25-1,821,765.48
联营、合营企业投资收益-647,615.46189,814.34-1,416,742.16-1,821,765.48
汇兑净收益--------
四、营业利润60,605,832.37399,674,606.98339,278,525.57286,828,419.81
营业外收入17,678.033,665,249.443,697,615.453,604,057.93
营业外支出305,858.573,475,751.51,091,598.38777,502.23
非流动资产处置净损失----241,105.2187,315.47
五、利润总额60,317,651.83399,864,104.92341,884,542.64289,654,975.51
所得税15,549,202.0757,507,433.4856,324,981.0845,884,077.14
未确认的投资损失--------
六、净利润(百万元)44.77342.22285.25243.46
少数股东损益--139,515.84310,249.18310,249.18
归属于母公司股东的净利润44,768,449.76342,217,155.6285,249,312.38243,460,649.19
七、每股收益0.030.220.180.15
基本每股收益0.030.220.180.15
稀释每股收益0.030.210.180.15
TOP↑